Outcomes and Cost Assessment of Acupuncture in the Treatment (OCAT) of Pain Patients at Malcolm Grow USAF Medical Center
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- Level of Pain at Conclusion of Study, as measured by using a 0-10 Numerical Rating Scale (NRS)
Study Overview
Brief Summary
The purpose of this project is to conduct a scientifically rigorous investigation of the clinical outcomes, quality of life, and cost associated with the delivery of acupuncture in the treatment of acute and chronic pain in patients at Malcolm Grow Medical Center, Andrews Air Force Base.
The specific aims of this study are to:
- Gather outcomes and patient satisfaction data on patients receiving acupuncture treatment for acute and chronic pain.
- Perform an analysis of costs, including any system cost savings, associated with providing acupuncture services to pain patients.
- Serve as a model to expand the project to Scott AFB and Travis AFB as per the request of the Air Mobility Command Surgeon General. (AMC/SG).
Detailed Description
Adult patients referred to the MGMC Acupuncture Clinic for this study must have an established Western medical diagnosis, have exhausted all standards of care for the reduction and/or resolution of pain, meet the inclusion and exclusion criteria and be clinically evaluated prior to entry in the study. 1000 patients will be entered into the study; no male and female patient ratios will be required. Patients under 18 years of age will be excluded. There are no upper age limits.
Acupuncture point(s) selection and acupuncture techniques will be individualized for each patient. All treatments will be approved by the physician principal investigator. Treatment will generally be administered with the patient either prone, supine, or seated position. Standards of reporting interventions in controlled trials of acupuncture, based on STRICTA requirements, will be followed. The following acupuncture data will be collected:
- Acupuncture point locations (palpation or electronic detection)
- Techniques employed: (e.g. dry needling, acupuncture, electro-acupuncture , auriculotherapy, electro-auriculotherapy, laser, piezo-electrical stimulation micro-current techniques, E-field)
- Types of needles employed (e.g. ASP gold/stainless steel, needle tacks, Seirin needles, etc.)
Baseline demographic data and information on pain levels (using the Numerical Rating Scale), patient satisfaction (using the Patient Satisfaction Questionnaire), functional health status (using the SF-8), and concomitant medical care (including medication use) will be collected prior to treatment. Follow-up data on pain levels and concomitant medical care will be collected via telephone 24 hours, 1 week, 2 weeks, and 4 weeks post-therapy. Patient satisfaction and functional health status data will be collecetd again at 4 weeks post-treatment. Relapses of pain will be noted and appropriately evaluated. In addition, the following clinical data will be collected:
- Subjective, Objective, Assessment, and Treatment(SOAP) parameters
- Medication use
- Range of motion
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Factorial
- Primary Purpose
- Diagnostic
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Western diagnosis of acute or chronic pain syndromes
- •Previously treated western standard of care
- •Written Informed Consent
- •Over the age of 18
Exclusion Criteria
- •Unwilling or unable to participate in study treatment and follow-up
- •Unable to give informed consent for any reason
- •Allergic reaction to adhesive tape, gold or other components of the acupuncture needles
- •Pregnancy
- •Pacemaker
- •Electronic stimulator of any sort
- •Herbal preparations
Outcomes
Primary Outcomes
Level of Pain at Conclusion of Study, as measured by using a 0-10 Numerical Rating Scale (NRS)
Time Frame: Baseline; Final assessment
Secondary Outcomes
- Pain Level, as measured by using a 0-10 Numerical Rating Scale (NRS) and Medication Use(Baseline; Immediately after tx; 24 hours after tx)